Formfactor FORM 深 滬
等待開盤 12-12 09:30:00 美东时间
58.13
-1.100
-1.86%
華盛通- 最 高58.89
- 今 開58.35
- 成交量 53.84万股
- 最 低 57.46
- 昨 收 59.23
- 總市值 44.83亿
- 52周最高 61.10
- 市盈率 靜 65.50
- 換手率 0.70%
- 52周最低 22.58
- 委 比 -12.50%
- 總股本 7711.42万
- 歷史最高 63.625
- 量 比 1.05
- 振 幅 2.41%
- 歷史最低 3.70
- 每 手 1
- 風險率 8.21%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
Cantor Fitzgerald Initiates Coverage On FormFactor with Overweight Rating, Announces Price Target of $75
Cantor Fitzgerald analyst Matthew Prisco initiates coverage on FormFactor (NASDAQ:FORM) with a Overweight rating and announces Price Target of $75.
11-18 22:01
美股牛股 | CMBM涨超27%！与星链携手推出全新集成网络方案；医疗股GH绩后大涨近28%
CMBM涨超27%！与星链携手推出全新集成网络方案；Q3收入同比增长39%超预期，医疗股GH绩后大涨近28%；MTSR涨超22%，拟获诺和诺德要约收购>>
10-31 14:55
美股大行评级 | 最高350美元！16家大行上调谷歌目标价！Meta遭12家大行下调目标价；潜在涨幅1456.29%！NRX Pharmaceuticals获Ascendiant Capital升目标价至47美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持NRX Pharmaceuticals"买入"评级，目标价从46美元升至47美元；富国银行：维持Kyverna Therapeutics"超配"评级，目标价从27美元升至31美元
10-31 10:25
TD Cowen Maintains Hold on FormFactor, Raises Price Target to $50
TD Cowen analyst Krish Sankar maintains FormFactor (NASDAQ:FORM) with a Hold and raises the price target from $35 to $50.
10-31 04:19
FormFactor Announces Participation at Upcoming Conference
FormFactor, Inc. (NASDAQ:FORM) announced its participation in the 2025 Midwest 1x1 Conference, scheduled for November 6, 2025, at the Waldorf Astoria Chicago, featuring only one-on-one meetings. The company, a leading provider of essential test and measurement technologies for the entire IC life cycle, helps semiconductor companies optimize device performance and improve yield knowledge to accelerate profitability.
10-30 20:01
康菲中国总裁胡凯诚荣获中国政府友谊奖
北京2025年10月30日 /美通社/ -- 康菲石油中国有限公司（"康菲中国"）总裁胡凯诚（Markel Hübinette）先生荣获2025年度中国政府友谊...
10-30 11:12
美股盘后 | Formfactor涨12.53%
Formfactor预计近期公布2025年第三季度财报，分析师预期每股收益0.22美元，营收2亿美元，作为公司年度重要财务数据，市场关注其业绩表现是否达到预期。
10-30 05:24
FormFactor shares are trading higher after the company reported better-than-expected Q3 financial results and issued Q4 guidance above estimates.
FormFactor shares are trading higher after the company reported better-than-exp...
10-30 04:09
FormFactor Sees Q4 GAAP EPS $0.15-$0.23 vs $0.17 Est; Sees Sales $205.000M-$215.000M vs $200.754M Est
FormFactor (NASDAQ:FORM) is looking for Q4 GAAP EPS of $0.15-$0.23 vs $0.17 analyst estimate. sees sales of $205.000 million-$215.000 million vs $200.754 million analyst estimate.
10-30 04:04
